Express Scripts Holding Company (ESRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): How Obamacare’s $20 Billion Bonanza Is Bombing
Tucked away inside Obamacare are 18 pages that could create a new $20 billion-per-year market.
Posts Tagged ‘NYSE:TEVA’
Valeant Pharmaceuticals Intl Inc (VRX), Actavis Inc (ACT): Sticking With a Winning Strategy
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has built a unique, winning drug business by acquiring underperforming niche product franchises and incorporating them into its efficient...
Abbott Laboratories (ABT), Celgene Corporation (CELG) & Three Pharma Companies to Buy in 2013
Currently, a majority of pharma companies are facing the issue of generic competition.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Hedge Funds and Insiders Are Bearish, What Should You Do?
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) was in 47 hedge funds' portfolio at the end of March. TEVA has experienced a decrease in hedge fund sentiment of late.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Four Big Drug Companies With Big Juicy Yields
Drug companies have been revenue generating machines for long.
Pfizer Inc. (PFE)’s New Model
One of Pfizer Inc. (NYSE:PFE)'s best selling drugs is Viagra, which is used to treat erectile dysfunction.
Air Products & Chemicals, Inc. (APD), Hasbro, Inc. (HAS): Is There a Bubble Brewing?
The real-money Inflation-Protected Income Growth portfolio saw yet another gain last week, this time picking up around $711 -- or better than 2.3% of the $30,000 it started with...
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN): Statin Users May Have a Reason to Rejoice After This Data
Whether or not you've been keeping tabs, the American Society of Clinical Oncology's annual meeting is less than two weeks away.
Valeant Pharmaceuticals Intl Inc (VRX), Actavis Inc (ACT): How Would A Combined Company Look?
News that Montreal-based Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was in talks to merge with Parsippany, New Jersey-based Actavis Inc (NYSE:ACT) emerged barely a week after...
Arris Group Inc (ARRS), Fluor Corporation (NEW) (FLR), And Three Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
United Online, Inc. (UNTD), Pfizer Inc. (PFE): On This Day In Business-Econ History…
The first official recognition of Mother's Day occurred nearly a century ago, when on May 9, 1914, President Woodrow Wilson proclaimed the second Sunday in May would thereafter...
Antares Pharma Inc (ATRS) Q1 Results Unimpressive, but Otrexup Could Be Catalyst
Antares Pharma Inc (NASDAQ:ATRS) announced its first-quarter results Wednesday morning but failed to impress the market. Shares were down around 3% in midday trading.
Is Actavis Inc (ACT) a Buy at This Price?
Actavis Inc (NYSE:ACT), the largest generic drug company in the US, just got even bigger.
Amgen, Inc. (AMGN): Is It a Buy Now?
When it comes to biotechs, Amgen, Inc. (NASDAQ:AMGN) qualifies for the senior citizen discount.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Will The Transition Be Effective?
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), a pharmaceuticals company that makes money off of branded drugs as well as generics, is an interesting example of a company...
Gilead Sciences, Inc. (GILD) or Biogen Idec Inc. (BIIB)? This Is What the Perfect Biotech Would Look Like
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
Amgen, Inc. (AMGN): Can Earnings Keep It Soaring?
On Tuesday, Amgen, Inc. (NASDAQ:AMGN) will release its latest quarterly results.
Johnson & Johnson (JNJ): Will Dividend Growth for This Dividend King Start Slowing?
Johnson & Johnson (NYSE:JNJ) has been considered a dividend growth star for a number of years now.
Another Israel ETF Could Be On The Way
Van Eck's Market Vectors unit, the fifth-largest U.S.
Abbott Laboratories (ABT): This Company & Ache Labs: A Perfect Match?
Abbott Laboratories (NYSE:ABT) has begun its new future swimmingly.
Hedge Funds Are Selling Novo Nordisk A/S (ADR) (NYSE:NVO) – Forest Laboratories, Inc. (NYSE:FRX), Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY)
To most stock holders, hedge funds are assumed to be slow, outdated financial tools of the past.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Is One of 5 Key Stocks in This Healthcare-Focused Hedgie’s Portfolio
Healthcare stocks aren’t for everyone, but one way average investors can learn more about this space is by paying attention to those who make a career out of it.
Biogen Idec Inc. (BIIB), Sanofi SA (ADR) (SNY), Elan Corporation, plc (ADR) (ELN): The Greatest Thing Since Sliced Bread Has Arrived for MS Patients
Last November, I examined five experimental drugs that appeared as if they had all of the tools necessary to become life-changing blockbusters from a financial and quality of ...
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Is Amgen, Inc. (AMGN) a Cash King?
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Should You Buy Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)?
In the financial world, there are plenty of indicators shareholders can use to track the equity markets.
Abbott Laboratories (ABT), Biogen Idec Inc. (BIIB): Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Help You Retire Rich?
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Pfizer Inc. (PFE), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Decision Looms on New Multiple Sclerosis Drug
Will good news from Europe echo on this side of the Atlantic within the next few days? Biogen Idec Inc. (NASDAQ:BIIB) is certainly hoping so.
Air Products & Chemicals, Inc. (APD), Raytheon Company (RTN): The Cash Just Keeps Rolling In
In early December 2012, the Inflation-Protected Income Growth portfolio was launched.
2 Biopharmaceuticals With Huge Upside Potential: Galena Biopharma Inc (GALE), Oncolytics Biotech, Inc. (USA) (ONCY)
The Biopharmaceutical industry has been one of the most profitable industries last year.
What’s the Deal With Abbott Laboratories (ABT)? – Johnson & Johnson (JNJ), AbbVie Inc (ABBV)
There were cheers for joy when Abbott Laboratories (NYSE:ABT) announced that it would split itself into two entities -- separating the device and diagnostics businesses from ...
Actavis Inc (ACT) Profits Decrease As Acquisition Takes Toll: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mylan Inc. (MYL)
U.S. generics firm Actavis Inc (NYSE:ACT), previously Watson Pharmaceuticals, reported a strong jump in its revenues in the fourth quarter and total earnings for 2012.
Does Teva Pharmaceutical Industries Ltd (ADR) (TEVA)’s Dividend Have Room to Soar?
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed income positions and into stocks to find yield.
Down 35%! Spectrum Pharmaceuticals, Inc. (SPPI) Is a Biotech Trainwreck: Sagent Pharmaceuticals Inc (SGNT), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is hurting today after dialing back guidance for the year. Apparently the increased production by Sagent Pharmaceuticals Inc.
Will Abbott Laboratories (ABT) Labs Help You Retire Rich? – Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mead Johnson Nutrition CO (MJN)
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Antares Pharma Inc (ATRS) Earnings: An Early Look – Pfizer Inc. (PFE), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Earnings season is winding down, with most companies already having reported their quarterly results.
3 Reasons Why the Stock Market of 2013 Isn’t the Same as 2007: QUALCOMM, Inc. (QCOM), Caterpillar Inc. (CAT), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
It took more than five years, but the Dow Jones Industrial Average 2 Minute (Dow Jones Indices: .DJI) has officially surpassed its previous record.
Pharmaceutical Winners And Losers In Early 2013: Johnson & Johnson (JNJ), Sanofi SA (ADR) (SNY), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Ultimately, that was the loss of those optimists. As value investors, we are not afraid of bad news as long as we get compensated by low valuations.
Analyst Roundtable: Any Surprises in Amarin Corporation plc (ADR) (AMRN)’s Fourth Quarter?
Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to discuss Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a biotech that recently launched...
Will Novartis (NVS) Help You Retire Rich?
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Is Gilead Sciences, Inc. (GILD) Destined for Greatness?
Every investor can appreciate a stock that consistently beats the Street without getting ahead of its fundamentals and risking a meltdown.
The Fight Over This Biotech’s Cash: Elan Corporation, plc (ADR) (ELN)
Elan Corporation, plc (ADR) (NYSE:ELN) was nice enough to give us a little more detail on what it plans to do with the $3.25 million that the biotech stands to get from Biogen...
Can Abbott Laboratories (ABT) Grow This Global Business?
Between the patent cliff, taxes, and Europe's meltdown, there's enough information and legislation swirling about to keep concerned shareholders up for days.
Why NewLink Genetics Corp (NLNK) Is Poised to Underperform
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company NewLink Genetics Corp...
Is This the Start of Something Big? – Texas Instruments Incorporated (TXN) and More
Last week, the Inflation-Protected Income Growth portfolio received its first dividend payment, $9.87 worth of dividends on 47 shares of Texas Instruments Incorporated (NASDAQ...
Biogen Idec Inc. (BIIB): A Strong Growth Opportunity In Multiple Sclerosis
Biogen Idec Inc.(NASDAQ:BIIB) has just moved to reinforce its dominance in the multiple sclerosis treatment market by striking a deal to buy the 50% rights to Tysabri that it...
Spectrum Pharmaceuticals, Inc. (SPPI) Earnings: An Early Look
Earnings season is now starting to wind down, with most companies already having reported their quarterly results.
A Pipeline Worth Buying – Amgen, Inc. (AMGN)
The biotechnology industry is one of the most attractive industries for investors primarily due to its high returns.
Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Rule This Multibillion-Dollar Market?
Back in 2011, generic drug giant Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) dominated the MS field, riding the coattails of its Copaxone medication to success.
Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK): 2 Dow Stocks We All Need but Shouldn’t Own
Here at The Motley Fool, we believe the best way to invest and maximize returns is by buying strong companies and owning them for a long time.
Why Depomed Inc (DEPO) Is Poised to Pull Back
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, specialty pharmaceutical company Depomed...
